Analyst consensus rating
Genelux Analyst Rating: Strong Buy
GNLX is rated Strong Buy by 6 analysts with a $17.50 target. As of 2026-08-29.
Direct answer
Genelux's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.50.
Forecast evidence checked August 29, 2026.
Get free Genelux email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.66
- Average price target
- $17.50
- High price target
- $31.00
- Low price target
- $10.00
- Low target gap
- +275.9%
- Target upside
- +557.9%
- High target gap
- +1,065.4%
- Target range width
- 789.5%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Genelux?
Genelux has a verified Strong Buy consensus. The same dataset has an average price target of $17.50.
How far are Genelux's low and high targets from the recorded price?
The low target implies +275.9%, while the high target implies +1,065.4%.
How many analysts are included in Genelux's consensus?
The verified consensus includes 6 analysts.
How is Genelux's target upside or downside calculated?
The average target of $17.50 is divided by the recorded price of $2.66, then one is subtracted to produce +557.9%. This does not guarantee a future return.
When was Genelux's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.